chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ATRIAL FIBRILLATION; INABILITY TO SWALLOW; BLOOD CLOT IN RIGHT ARM; LOW BLOOD PRESSURE; DEATH 4 DAYS AFTER RECEIVING  VACCINE; This spontaneous report received from a vaccine facility via a company representative concerned a 95-year-old female. The patient's height, and weight were not reported. The patient's concurrent conditions included atrial fibrillation. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. It was reported that on an unspecified date in 2021 the patient received Janssen Covid-19 Vaccine and within 6hrs she had a major atrial fibrillation episode, then several the following day. The next day, she lost her ability to swallow. Two days later she was on oxygen. Three days later she developed a blood clot in her right arm, was still on oxygen and blood pressure was falling. On an unspecified date, the patient died 4 days after receiving vaccine. The action taken with COVID-19 VACCINE AD26.COV2.S was not applicable. The patient died 4 days after receiving vaccine on an unspecified date, and the outcome of atrial fibrillation, inability to swallow, blood clot in right arm and low blood pressure was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20210400509: This spontaneous report received from a vaccine facility via a company representative involved a 95-year-old female with the past medical history remarkable for atrial fibrillation who received the Janssen COVID-19 Vaccine for prevention of COVID-19 infection and within 6hrs had a major atrial fibrillation episode. No concomitant medications were reported. The next day, she lost her ability to swallow. Two days later she was on oxygen. Three days later she developed a blood clot in her right arm, was still on oxygen and blood pressure was falling. On an unspecified date, the patient died 4 days after receiving vaccine. No information was provided regarding the cause of death.  Considering the patient's past medical history of atrial fibrillation, the causality for the event of atrial fibrillation, as well the consequent events is assessed not related to the Janssen COVID-19 Vaccine.; Reported Cause(s) of Death: DEATH 4 DAYS AFTER RECEIVING VACCINE
BEgan around 2:10 pm, itching throat; facial rash and ear rash. Seen by Nurse Practioner at that time.  Benadry 25mg IM given at 2:25pm. Improved. No wheeze or other respiratory s/s.  Discharged home at 4:10pm. NP advised not receiving second dose.
I tested positive for Covid-19 on November 30, 2022 my symptoms were congestion, sore throat, fever, body aches I was prescribed PAXLOVID for my symptoms.
Client received a FLUARIX QUADRIVALENT vaccine from us in her R deltoid on 10-11-2016 for work. She called our office today with complaint that she has had persistent arm pain that developed 2 days after receiving the flu shot. She says she felt fine right after receiving the shot, however 2 days later she developed R arm soreness localized to the injection site. No redness, itching, significant swelling. She says 2 days after she also felt nauseous, sweaty, feverish although this only lasted a few days. She also at that time developed R hip pain that persisted for several weeks up until last week when it finally resolved. She no longer has hip pain. She has never had any radiculopathy of her R extremity. No numbness, tingling or shooting pain. She denies any decrease in function of her arm. Has FROM and full grip strength. No Arm weakness. At this time her only symptom is localized pain to the injection site that is sore to touch. She rates the pain 4/10. She does notice the discomfort at times even without touching the site, but it is mild. She has tried Ibuprofen.
3rd HPV given on 2/1/17, previously healthy. Returned on 3-2-17 with fatigue and dizziness. Seen on 3/7/17 with fatigue, dizziness, decreased appetite. 3-15-17 symptoms increased, exhaustion. 3/24/17 dizzy, tired, hyperacusia, legs shaking.
10 days later, new rash on lower extremities, nodular. Did not recur with second dose, unclear if related.
Patient vomited minutes after receiving DTaP and Influenza immunizations. Patient was also suddenly pale and sweaty. Her temperature was 97.2. She sat on moms lap and color returned to normal.
pt recv vax 17JAN97 & 22JAN97 pt exp measles-like rash, malaise, & a sore throat not strep;@ the time of the report measles-like rash persisted;
Patient scheduled to receive a 2nd dose of Pfizer vaccine on 4/16 at our community clinic. Unfortunately patient received a Moderna dose and not a Pfizer 2nd  dose. Patient at this time is not reporting any adverse reactions.
Uncontrolable shaking, couldn't breathe. Severe body aches, difficult and painful to move. Severe headache. Fever of 102.5 degrees.
Tired day receiving vaccine; 11/23/16 "lump in throat"; right sided cramping from jawline to fingertips, difficulty moving right arm, coughing and wheezing. Patient stated symptoms lasted until Monday. 11/28/16. No current symptoms. Patient states previous reaction with Hepatitis B vaccine 11/2013 of wheezing and coughing, but did not inform anyone.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients may had been vaccinated with improperly stored VARIVAX (Merck) (dose, frequency, route of administration, lot# and expiration date were not reported). No adverse events were reported. No product quality complain (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pt was 17 years old when vaccinated, verbal consent received from patient's guardian to proceed with vaccination.
Child developed left eye tic 2 days after receiving her  first covid vaccine. The tic involves the  blinking of her left eye uncontrollably. The child has no previous history of tics or family history of tics, She reports no eye pain or vision changes associated with the tic. . Mother reports that it appears that the tic is increasing in frequency since she first noticed it.
Patient had fevers and malaise the day after the vaccine, recovered, but then developed chest pain with exertion and fatigue apprx 4-5 days after the vaccine.  Symptoms persisted with worsening shortness of breath and he then presented to the ED on 6/28/21.  He was found to have mildly elevated troponin and ST segment elevation.  He was admitted, monitored, and had normalization of troponin levels over the next 24 hours as well as resolution of symptoms.  Echocardiogram was normal.  He was discharged on 6/29/21 with a Holter monitor and outpatient Cardiology follow up.
Pt received FLUMIST in clinic - later that evening pt developed croup-like cough. Mom took him outside, gave tx of PULMICORT/XOPENEX - dad is MD and gave dose ORAPRED - much better by AM- gave PULM/XOPENEX BID finished 3d course ORAPRED- Did not take to ER or bring in office to be seen.
He presented to the ED with abdominal pain with diarrhea and depression. Had recent contact with 2 family members that were COVID positive. Does report having a cough but no shortness of breath or chest pain. CT scan showered patchy groundglass opacities which likely represents COVID pneumonia.  Not requiring oxygen at this time.
This case was reported by a physician and described the occurrence of chest tightness in a 28-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). There were no concurrent medications. On 11 June 2012 the subject received "1st booster dose" of BOOSTRIX (unknown, left arm). On 11 June 2012, less than one day after vaccination with BOOSTRIX, the subject experienced chest tightness and arm pain. At the time of reporting the arm pain resolved on an unspecified date and the outcome of the chest tightness was unspecified. At the time of the report no additional information was available.
HPV # 3 given in error. Spoke to PCP and family. No adverse reactions noted at this time.
Around 10:30 pm started with chills, awoke at 2:30 am with chills/shaking, unable to go back to sleep.  The next day continued with chills until took Tylenol around 11 am, then no further chills, just body ache and tired.  Checked temperature several times, and did not have temperature at any time.
patient has an egg allergy and developed some asthma symptoms after vaccination. She took Claritin and did not need additional medical treatment
Injection area hot to touch after 1st dose; Discomfort at injection area after 1st dose; Arm sore after 1st dose; Injection area red after 1st dose; Injection area swollen after 1st dose; Pain at injection area after 1st dose/Injection area a little painful after 1st dose still; Injection area a little itchy after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection area hot to touch after 1st dose), VACCINATION SITE REACTION (Discomfort at injection area after 1st dose), MYALGIA (Arm sore after 1st dose), VACCINATION SITE ERYTHEMA (Injection area red after 1st dose) and VACCINATION SITE SWELLING (Injection area swollen after 1st dose) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042b21-2a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection area hot to touch after 1st dose), VACCINATION SITE REACTION (Discomfort at injection area after 1st dose), MYALGIA (Arm sore after 1st dose), VACCINATION SITE ERYTHEMA (Injection area red after 1st dose), VACCINATION SITE SWELLING (Injection area swollen after 1st dose), VACCINATION SITE PAIN (Pain at injection area after 1st dose/Injection area a little painful after 1st dose still) and VACCINATION SITE PRURITUS (Injection area a little itchy after 1st dose). At the time of the report, VACCINATION SITE WARMTH (Injection area hot to touch after 1st dose), VACCINATION SITE REACTION (Discomfort at injection area after 1st dose), MYALGIA (Arm sore after 1st dose), VACCINATION SITE ERYTHEMA (Injection area red after 1st dose), VACCINATION SITE SWELLING (Injection area swollen after 1st dose), VACCINATION SITE PAIN (Pain at injection area after 1st dose/Injection area a little painful after 1st dose still) and VACCINATION SITE PRURITUS (Injection area a little itchy after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: MUCINEX FAST MAX COLD & FLU; LEXAPRO; OMEPRAZOLE. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  Clinical course: The patient received covid-19 treatment (Pfizer brand) from 21May2022 to 25May2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Starting the evening of 04/26/2022, I started noticing a pain in the back of my left ear and left side of the neck. When I woke up in the am, the left side of my face was numb. Over the next few hours, it got worse to the point where I was unable to blink my left eye. The next morning I made an appt with my PCP on 04/28/2022. I was prescribed valacyclovir and prednisone for 7 days for Bell's Palsy. The next day I saw my ophthalmologist. The prednisone, while in my system, helped me to blink my eye and resolved all of the pain. Since stopping the prednisone, and it being out of my system, I am unable to blink my eye again and it feels like the pain has come back even worse than before.
This case was received from a nurse on 21.Mar.2012. This case concerns a 18-year-old female patient who had received oral Typhoid vaccine (batch no: not reported). The patient had no known drug allergies. Concomitant medication was included TRIVORA and multivitamins. On 23.Feb.2012, the patient took the first capsule of VIVOTIF. On the same day, one hour after vaccine intake, the patient experienced dizziness and nausea. She also developed red and itchy hives on chest. All symptoms resolved within 24 hours. She discontinued the oral vaccination and after having consulted a physician she received injectable Typhoid vaccination on 09.Mar.2012 without problems. This case was considered non-serious.
Patient received the 1st COVID vaccine Pfizer, lot #EW0182 EXP 08/2021 at 2:24 PM in her right deltoid muscle. Client alerted EMT in the observation area about 20 minutes into her observation time. EMT responded to the client. Client reported feeling tightness and numbness in her lower extremities bilaterally. Client was to wait in the observation area for 30 minutes due to history of "face swelling" after taking Amoxicillin. The client sought emergency services following this incident, and denies any medications given at the time. Lead RN and Co-lead RN presented to the client at 2:52 PM. The client was escorted to the anti-gravity chair by EMT. Client denied any itching, swelling of her throat, or SOB. No swelling was noted by RN around the patient's face and mouth. Vitals taken by EMT at 2:52PM were as follows: HR: 73, O2 97%, and HR 80. Pupils equal, round, and reactive to light. Client reports a history of hypertension and diabetes mellitus II. Current medications include Aspirin, Lisinopril, Janumet, and Lipitor. She stated that she takes her BP medications in the evening, and hasn't taken a dose since last night. At 2:56 PM, the client was reclined in the anti-gravity chair. Client denied headache, shortness of breath, or chest pain at the time. No erythema/redness or swelling were noted at the vaccination site, right deltoid. Client was offered water at this time. Repeat vitals by EMT at 3:01 were as follows: BP 120/85, HR 73, O2 96%. Physical assessment by RN demonstrated L radial pulse 2+, bilateral pedal pulses 2+. Client stated the "numbness is getting better". Pedal strength equal bilaterally and hand grasp strength equal bilaterally. Client's smile was equal bilaterally. Bilateral pedal capillary refill <2 seconds. Client denies any history of a circulatory disorder or diagnosis. The client reported her last vaccination was a flu vaccination approximately 5 years ago. At 3:04 PM, the client was assisted to a standing position by RN. The client stated she "feels better." Client was then seated again in the anti-gravity chair without assistance. Due to persistent symptoms RN discussed medical treatment options which included calling 911 for further evaluation, or seeking urgent care services. The client declined EMS services and transport to hospital. Client stated she would prefer to seek treatment at a different Hospital with her husband today. Education was provided regarding signs and symptoms of anaphylaxsis, when to seek EMS services, to follow up with PCP within 1 week regarding reaction and BP, V-SAFE. Client voiced understanding of this. Vitals obtained by EMT at 3:11 PM were BP 130/90, HR 76, O2 97%. Client's husband entered the facility. The client and her husband voiced plans to seek services at other Hospital following discharge from the vaccination site. Client was discharged. Client exited the facility with a steady unassisted gait, into a personal vehicle driven by her husband at 2:26 PM.
Injection Thursday felt fine, Friday night tired, Saturday very tired, Sunday - shingles emerged, Monday started valacyclovir  felt a better Tuesday extreme headache, very fatigued, couldn't eat, stomache issues, no fever shingles much better, went to ER thought I had an infection (I am susceptible to infection without ioncreased white count and fever)  They gave me fluids and torridal.  Wednesday symptoms have lessened but still headahce and tired.  Maybe a reaction to vaccine???   Mild fatigue with first 2 shots
My left shoulder has been in pain from September 3rd till present (today is September 25) . Also I have noticed more swelling around a bump I have in the same arm .  Also , I feel like the way I poop has changed . I feel like I poop smaller and less than before . (This has occurred from September 3rd till present )
When caller received the other 3 doses, caller just had a sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient received BNT162b2 (BNT162B2), on 12Mar2021 as dose 1, single (Lot number: EP6955) at the age of 60 years, on 02Apr2021 as dose 2, single (Lot number: PR8734) and on 24Oct2021 as dose 3 (booster), single (Lot number: FF2590) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "When caller received the other 3 doses, caller just had a sore arm".  Additional information: The patient also received BNT162b2 (BNT162B2), on 31May2022 at 15:00 as dose 4 (booster), 1.8 ml single (Lot number: 9729) at the age of 61 years for covid-19 immunisation.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200793526 same patient and drug, different dose/different event separated in time
Difficulty speaking; Difficulty reading; This spontaneous case was reported by a consumer and describes the occurrence of SPEECH DISORDER (Difficulty speaking) and READING DISORDER (Difficulty reading) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.    On 03-Mar-2021 at 6:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced SPEECH DISORDER (Difficulty speaking) and READING DISORDER (Difficulty reading). At the time of the report, SPEECH DISORDER (Difficulty speaking) outcome was unknown and READING DISORDER (Difficulty reading) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Fever, Chills, Nausea, sore joints, pain at injection site, stomach ache, diarrhea, tiredness, headache,
Woke up in the middle of the night with a hugely swollen tongue. Also had sensitivity to light and discomfort on cheeks of face. Was given epinephrin and demerol. Was observed for 4 hours and released to come home. Tongue swelling completely gone by 3 pm and other symptoms by next morning.
Patient received vaccine Hep A on 05/06/2003 in late morning.  Patient went to school and in afternoon developed right side facial pain and weakness.  Diagnosis as Ball's Palsy.  (Patient had similar symptoms twice and recovered, not associated with vaccines).  In past 5 days much better.
First dose - 01/05/2021 - reaction - red swollen arm at injection site, bruised, hot to touch. No treatment sought. 2nd dose - 02/11/2021 - approximately 3 hours post vaccine face swelling, severe hives, tongue/throat swollen, called 911. EPI given at home and then taken to hospital. Discharge summary severe anaphylactic shock.  Admitted to hospital same day, discharged within 7 hours.
Started feeling lethargic and like his legs were "tired and hard to move because they were heavy" accompanied by an upset stomach and sore throat but no fever, checked by elementary school secretary at 10:45 AM. By 11:20 AM he registered a fever of 102.5 at the doctor's office with a mild headache. By 2 p.m. his lymph nodes were hard as rocks and swollen to the point of being outwardly visible. Complete loss of appetite, increased lethargy, continued fever, and increased head pain by 8:00 PM.
Patient received first dose moderna vaccine on 7/12/21 at approximately 1235. Patient requested assistance due to "having an allergic reaction" at 1250. Patient reports, feeling "a little dizzy", lips tingling, and "it feels like when I go into a-fib." Initial vital signs: 140/70, 80 HR, 95% on RA, 17 RR. Patient stated during initial vital signs that her symptoms were resolving. Patient denied any shortness of breath, throat swelling or chest pain. Requested patient remain for 10-15 additional minutes of monitoring. At 1305 patient stated symptoms were resolved. Vital signs as follows: 130/72, 83 HR, 16 RR, 93% on RA.
Starting April 26th the patients legs started kicking like riding a bike. This happened around 1-2 times a day. Starting May 5th when her legs would kick her hands started making moving rhythmically as well. This would happen 2-3 times a day. Starting May 9th her eyes started going back and forth during the movements with legs and arms. She started having 4-5 a day.
Patient came into the pharmacy tonight extremely upset wanting to report an adverse reaction to a vaccine. She received both Fluvirin and Pneumovax 23 on 11/15. She reports feeling loss of appetite, muscle weakness, headache, fever, muscle and joint pain in the back of her legs and in her arms, and swollen glands. She saw a doctor in regards to a rash and swollen elbow joint below the injection site. Both injections were given in her left deltoid approximately one inch apart. The doctor prescribed ibuprofen, and the patient reports that the doctor is doing a blood test to determine the need for antibiotics.
FELT AWFUL; Ache; SORE ARM; WEIGHT LOSS 5 LBS; HEADACHE; COULD NOT GET WARM; SWEATING; LOSS OF APPETITE; TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On 02-APR-2021, the subject experienced tired. On 03-APR-2021, the subject experienced sweating. On 03-APR-2021, the subject experienced loss of appetite. On 03-APR-2021, the subject experienced could not get warm. On 03-APR-2021, the subject experienced headache. Laboratory data included: Weight (NR: not provided) Loss 5 LBS. On 04-APR-2021, the subject experienced weight loss 5 lbs. On an unspecified date, the subject experienced felt awful, ache, and sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from sweating, and the outcome of sore arm, tired, could not get warm, headache, loss of appetite, weight loss 5 lbs, felt awful and ache was not reported. This report was non-serious.
Migraine on 10/24-10/25. Shingles diagnosed on 10/27 symptoms first appeared 10/25 in the evening. Symptoms include rash, pain and light sensitivity. All symptoms are on the left side and this is also the side of the innoculation.